Company · CIK 0001419600 · SIC 2834 — Pharmaceutical Preparations
Flexion Therapeutics Inc · FLXN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2019 PForm 4 → | Mar 13, 4:11 pm EDT | Michael D. ClaymanPresident and CEO, Director | 4,046 | $12.36 | $50,009 | 70,856 | +6.06% | plan? |
| Mar 1, 2019 AForm 4 → | Mar 5, 6:18 pm EST | Kerry WentworthChief Regulatory Officer | 36,000 | — | — | 50,607 | — | plan? |
| Mar 1, 2019 AForm 4 → | Mar 5, 5:32 pm EST | Scott KelleyChief Medical Officer | 36,000 | — | — | 51,271 | — | plan? |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:30 pm EST | Christina WillwerthChief Strategy Officer | 36,000 | — | — | 58,419 | — | plan? |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:29 pm EST | Mark S. LevineGeneral Counsel | 36,000 | — | — | 45,060 | — | plan? |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:27 pm EST | David ArkowitzChief Financial Officer | 36,000 | — | — | 85,172 | — | plan? |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:26 pm EST | Neil BodickChief Scientific Officer | 36,000 | — | — | 100,782 | — | plan? |
| Jan 3, 2019 SForm 4 → | Jan 4, 5:12 pm EST | Mark S. LevineGeneral Counsel | 734 | $12.36 | $9,072 | 9,060 | −7.49% | plan? |
| Jan 3, 2019 SForm 4 → | Jan 4, 5:10 pm EST | Kerry WentworthChief Regulatory Officer | 622 | $12.36 | $7,688 | 11,207 | −5.26% | plan? |
| Jan 3, 2019 SForm 4 → | Jan 4, 5:09 pm EST | Scott KelleyChief Medical Officer | 622 | $12.36 | $7,688 | 15,271 | −3.91% | plan? |
| Jan 3, 2019 SForm 4 → | Jan 4, 5:06 pm EST | Neil BodickChief Scientific Officer | 746 | $12.36 | $9,221 | 64,782 | −1.14% | plan? |
| Jan 3, 2019 SForm 4 → | Jan 4, 5:03 pm EST | Michael D. ClaymanPresident and CEO, Director | 3,278 | $12.36 | $40,516 | 66,810 | −4.68% | plan? |
| Dec 20, 2018 JForm 4 → | Jan 4, 2019, 5:07 pm EST | David ArkowitzChief Financial Officer | 922 | $10.48 | $9,663 | 49,172 | — | plan? late |
| Nov 9, 2018 PForm 4 → | Nov 13, 9:17 am EST | Michael D. ClaymanPresident and CEO, Director | 5,000 | $17.10 | $85,477 | 69,166 | +7.79% | plan? |
| Nov 9, 2018 PForm 4 → | Nov 13, 9:14 am EST | David ArkowitzChief Financial Officer | 4,000 | $16.56 | $66,222 | 48,250 | +9.04% | plan? |
| Oct 8, 2018 FMForm 4 → | Oct 9, 5:08 pm EDT | Neil BodickChief Scientific Officer | 5,911 | $18.60 | $25,017 | 65,528 | — | plan? |
| Oct 8, 2018 FMForm 4 → | Oct 9, 4:31 pm EDT | Michael D. ClaymanPresident and CEO, Director | 21,033 | $18.60 | $115,934 | 83,849 | — | plan? |
| Oct 8, 2018 FForm 4 → | Oct 9, 4:30 pm EDT | Kerry WentworthChief Regulatory Officer | 1,002 | $18.60 | $18,637 | 11,476 | — | plan? |
| Oct 6, 2018 FMForm 4/A → | Mar 5, 2019, 8:17 pm EST | Kerry WentworthChief Regulatory Officer | 4,402 | $18.60 | $18,637 | 14,876 | — | plan? |
| Aug 9, 2018 PForm 4 → | Aug 10, 12:56 pm EDT | David ArkowitzChief Financial Officer | 4,000 | $23.42 | $93,680 | 44,250 | +9.94% | plan? |
| Aug 9, 2018 PForm 4 → | Aug 10, 9:13 am EDT | Michael D. ClaymanPresident and CEO, Director | 10,000 | $22.33 | $223,300 | 75,282 | +15.3% | plan? |
| Jul 2, 2018 SForm 4 → | Jul 3, 4:07 pm EDT | Neil BodickChief Scientific Officer | 50,000 | $25.07 | $1,253,492 | 62,307 | −44.5% | plan? |
| Jun 20, 2018 JForm 4 → | Jun 22, 4:37 pm EDT | Kerry WentworthChief Regulatory Officer | 171 | $21.22 | $3,629 | 12,478 | — | plan? |
| Jun 20, 2018 JForm 4 → | Jun 22, 4:35 pm EDT | Scott KelleyChief Medical Officer | 1,001 | $21.22 | $21,241 | 15,893 | — | plan? |
| Jun 20, 2018 JForm 4 → | Jun 22, 4:33 pm EDT | Michael D. ClaymanPresident and CEO, Director | 554 | $21.22 | $11,756 | 65,282 | — | plan? |
| Jun 20, 2018 JForm 4 → | Jun 22, 4:30 pm EDT | Mark S. LevineGeneral Counsel | 539 | $21.22 | $11,438 | 8,872 | — | plan? |
| Jun 1, 2018 AForm 4 → | Jun 4, 4:26 pm EDT | David ArkowitzChief Financial Officer | 30,000 | — | — | 40,250 | — | plan? |
| May 11, 2018 MForm 4 → | May 11, 4:07 pm EDT | Neil BodickChief Scientific Officer | 37,702 | $0.1626 | $6,130 | 112,307 | — | plan? |
| Feb 27, 2018 GForm 4 → | Nov 13, 9:17 am EST | Michael D. ClaymanPresident and CEO, Director | 39,366 | — | — | 314,066 | — | plan? late |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:48 pm EST | Kerry WentworthChief Regulatory Officer | 8,333 | — | — | 12,307 | — | plan? |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:47 pm EST | Scott KelleyChief Medical Officer | 8,333 | — | — | 14,892 | — | plan? |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:45 pm EST | Mark S. LevineGeneral Counsel | 8,333 | — | — | 8,333 | — | plan? |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:41 pm EST | Michael D. ClaymanPresident and CEO, Director | 29,167 | — | — | 64,728 | — | plan? |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:39 pm EST | Neil BodickChief Scientific Officer | 10,000 | — | — | 74,605 | — | plan? |
| Dec 20, 2017 JForm 4 → | Dec 22, 5:05 pm EST | Michael D. ClaymanPresident and CEO, Director | 166 | $16.59 | $2,754 | 35,561 | — | plan? |
| Dec 20, 2017 JForm 4 → | Dec 22, 4:59 pm EST | Scott KelleyChief Medical Officer | 858 | $16.59 | $14,234 | 6,559 | — | plan? |
| Nov 21, 2017 PForm 4 → | Nov 22, 5:28 pm EST | Neil BodickChief Scientific Officer | 2,700 | $24.49 | $66,112 | 1,000 | — | plan? |
| Nov 8, 2017 PForm 4 → | Nov 9, 9:13 am EST | Michael D. ClaymanPresident and CEO, Director | 5,000 | $23.60 | $118,000 | 35,395 | +16.5% | plan? |
| Oct 6, 2017 FMForm 4 → | Oct 10, 4:43 pm EDT | Neil BodickChief Scientific Officer | 6,164 | $29.93 | $47,835 | 62,905 | — | plan? |
| Oct 6, 2017 FMForm 4 → | Oct 10, 4:39 pm EDT | Michael D. ClaymanPresident and CEO, Director | 20,594 | $29.93 | $173,443 | 30,395 | — | plan? |
| Aug 31, 2017 PForm 4 → | Sep 15, 5:12 pm EDT | Yamo DenizChief Medical Officer | 5,375 | $24.48 | $131,575 | 9,000 | +148% | plan? late |
| Jun 20, 2017 JForm 4 → | Jun 23, 6:36 pm EDT | Michael D. ClaymanPresident and CEO, Director | 1,243 | $15.37 | $19,105 | 21,389 | — | plan? late |
| Jun 16, 2017 PForm 4 → | Jun 20, 4:24 pm EDT | Mark StejbachDirector | 1,580 | $17.02 | $26,888 | 1,580 | — | plan? |
| Jun 5, 2017 PForm 4 → | Jun 6, 6:49 pm EDT | Samuel D ColellaDirector, 10% Owner | 5,000 | $17.01 | $85,048 | 5,000 | — | plan? |
| Jun 5, 2017 PForm 4 → | Jun 6, 6:47 pm EDT | Michael D. ClaymanPresident and CEO, Director | 5,000 | $17.23 | $86,152 | 20,146 | +33.0% | plan? |
| May 15, 2017 SForm 4/A → | May 19, 4:34 pm EDT | Neil BodickChief Medical Officer | 6,830 | $18.95 | $129,448 | 59,937 | −10.2% | plan? |
| May 15, 2017 MForm 4/A → | May 19, 4:34 pm EDT | Neil BodickChief Medical Officer | 6,830 | $2.52 | $17,214 | 66,767 | — | plan? |
| May 15, 2017 SForm 4 → | May 17, 4:15 pm EDT | Neil BodickChief Medical Officer | 6,830 | $18.95 | $129,448 | 39,107 | −14.9% | plan? amended |
| Apr 17, 2017 SForm 4/A → | May 19, 4:32 pm EDT | Neil BodickChief Medical Officer | 5,000 | $28.23 | $141,132 | 59,937 | −7.70% | plan? |
| Apr 17, 2017 MForm 4/A → | May 19, 4:32 pm EDT | Neil BodickChief Medical Officer | 5,000 | $2.52 | $12,602 | 64,937 | — | plan? |
| Apr 17, 2017 SForm 4 → | Apr 18, 7:45 pm EDT | Neil BodickChief Medical Officer | 5,000 | $28.23 | $141,132 | 45,937 | −9.82% | plan? amended |
| Mar 23, 2017 SForm 4 → | Mar 24, 4:24 pm EDT | Frederick W DriscollChief Financial Officer | 3,000 | $23.00 | $69,000 | 7,777 | −27.8% | plan? |
| Mar 23, 2017 MForm 4 → | Mar 24, 4:24 pm EDT | Frederick W DriscollChief Financial Officer | 3,000 | $7.89 | $23,658 | 10,777 | — | plan? |
| Mar 17, 2017 SForm 4/A → | May 19, 4:31 pm EDT | Neil BodickChief Medical Officer | 5,000 | $20.41 | $102,038 | 59,937 | −7.70% | plan? |
| Mar 17, 2017 MForm 4/A → | May 19, 4:31 pm EDT | Neil BodickChief Medical Officer | 5,000 | $2.52 | $12,602 | 64,937 | — | plan? |
| Mar 17, 2017 SForm 4 → | Mar 20, 7:42 pm EDT | Neil BodickChief Medical Officer | 5,000 | $20.41 | $102,038 | 50,937 | −8.94% | plan? amended |
| Feb 28, 2017 SForm 4 → | Mar 2, 4:56 pm EST | Frederick W DriscollChief Financial Officer | 33,434 | $19.97 | $667,679 | 7,777 | −81.1% | plan? |
| Feb 28, 2017 MForm 4 → | Mar 2, 4:56 pm EST | Frederick W DriscollChief Financial Officer | 30,000 | $7.89 | $236,583 | 41,211 | — | plan? |
| Feb 24, 2017 SForm 4/A → | May 19, 4:28 pm EDT | Neil BodickChief Medical Officer | 5,000 | $19.15 | $95,758 | 59,937 | −7.70% | plan? |
| Feb 24, 2017 MForm 4/A → | May 19, 4:28 pm EDT | Neil BodickChief Medical Officer | 4,000 | $2.52 | $10,081 | 64,937 | — | plan? |
| Feb 24, 2017 SForm 4 → | Feb 27, 4:17 pm EST | Neil BodickChief Medical Officer | 5,000 | $19.15 | $95,758 | 55,937 | −8.21% | plan? amended |
| Jan 20, 2017 SForm 4 → | Jan 23, 7:10 pm EST | Neil BodickChief Medical Officer | 5,000 | $18.35 | $91,747 | 60,937 | −7.58% | plan? |
| Dec 21, 2016 SForm 4 → | Dec 22, 4:40 pm EST | Neil BodickChief Medical Officer | 10,000 | $18.46 | $184,628 | 65,937 | −13.2% | plan? |
| Dec 20, 2016 JForm 4 → | Dec 27, 5:00 pm EST | Frederick W DriscollChief Financial Officer | 1,134 | $9.01 | $10,217 | 10,531 | — | plan? late |
| Dec 20, 2016 JForm 4 → | Dec 27, 4:58 pm EST | Michael D. ClaymanPresident and CEO, Director | 147 | $9.01 | $1,324 | 30,868 | — | plan? late |
| Dec 1, 2016 PForm 4 → | Dec 5, 2:40 pm EST | Samuel D ColellaDirector, 10% Owner | 10,000 | $16.38 | $163,807 | 43,333 | +30.0% | plan? |
| Nov 23, 2016 PForm 4 → | Nov 23, 8:17 pm EST | Michael D. ClaymanPresident and CEO, Director | 1,667 | $18.41 | $30,688 | 30,721 | +5.74% | plan? |
| Nov 22, 2016 PForm 4 → | Nov 23, 8:35 am EST | Michael D. ClaymanPresident and CEO, Director | 1,666 | $17.95 | $29,900 | 29,054 | +6.08% | plan? |
| Nov 21, 2016 PForm 4 → | Nov 22, 6:40 pm EST | Samuel D ColellaDirector, 10% Owner | 33,333 | $18.00 | $599,994 | 33,333 | — | plan? |
| Nov 21, 2016 PForm 4 → | Nov 22, 2:28 pm EST | Michael D. ClaymanPresident and CEO, Director | 1,666 | $17.90 | $29,827 | 27,388 | +6.48% | plan? |
| Jun 21, 2016 GForm 4 → | Mar 10, 2017, 5:03 pm EST | Michael D. ClaymanPresident and CEO, Director | 31,444 | — | — | 294,383 | — | plan? late |
| Jun 20, 2016 PForm 4 → | Jun 22, 1:36 pm EDT | Samuel D ColellaDirector, 10% Owner | 25,504 | $13.71 | $349,600 | 25,504 | — | plan? |
| Jun 14, 2016 PForm 4 → | Jun 16, 5:59 pm EDT | C Ann MerrifieldDirector | 1,000 | $13.39 | $13,387 | 2,000 | +100% | plan? |
| Jun 8, 2016 PForm 4 → | Jun 10, 9:40 pm EDT | Barbara N Lubash +310% Owner | 714,285 | $14.00 | $9,999,990 | 20,739 | — | plan? |
| Jun 8, 2016 PForm 4 → | Jun 10, 9:16 pm EDT | Versant Ventures III, LLC +910% Owner | 714,285 | $14.00 | $9,999,990 | 20,739 | — | plan? |
| Jun 8, 2016 PForm 4 → | Jun 10, 8:25 pm EDT | Samuel D ColellaDirector, 10% Owner | 714,285 | $14.00 | $9,999,990 | 20,739 | — | plan? |
| May 23, 2016 MForm 4 → | May 24, 5:26 pm EDT | Michael D. ClaymanPresident and CEO, Director | 10,369 | $0.1626 | $1,686 | 25,722 | — | plan? |
| May 20, 2016 JForm 4 → | May 24, 5:25 pm EDT | Frederick W DriscollChief Financial Officer | 963 | $8.92 | $8,590 | 9,397 | — | plan? |
| May 20, 2016 PForm 4 → | May 23, 4:04 pm EDT | Michael D. ClaymanPresident and CEO, Director | 2,000 | $10.41 | $20,810 | 13,568 | +17.3% | plan? |
| May 19, 2016 PForm 4 → | May 20, 5:52 pm EDT | Michael D. ClaymanPresident and CEO, Director | 2,000 | $9.65 | $19,297 | 11,568 | +20.9% | plan? |
| May 19, 2016 PForm 4 → | May 20, 5:51 pm EDT | Neil BodickChief Medical Officer | 850 | $10.00 | $8,500 | 75,937 | +1.13% | plan? |
| May 18, 2016 PForm 4 → | May 19, 5:30 pm EDT | Michael D. ClaymanPresident and CEO, Director | 2,000 | $10.23 | $20,465 | 9,568 | +26.4% | plan? |
| May 18, 2016 PForm 4 → | May 19, 5:29 pm EDT | Neil BodickChief Medical Officer | 2,100 | $10.20 | $21,420 | 75,087 | +2.88% | plan? |
| May 17, 2016 PForm 4 → | May 18, 5:23 pm EDT | Frederick W DriscollChief Financial Officer | 2,500 | $9.87 | $24,668 | 8,434 | +42.1% | plan? |
| May 17, 2016 PForm 4 → | May 18, 5:22 pm EDT | Michael D. ClaymanPresident and CEO, Director | 2,000 | $9.73 | $19,465 | 7,568 | +35.9% | plan? |
| May 17, 2016 PForm 4 → | May 18, 5:21 pm EDT | Neil BodickChief Medical Officer | 800 | $9.60 | $7,680 | 72,987 | +1.11% | plan? |
| May 16, 2016 PForm 4 → | May 17, 6:12 pm EDT | Frederick W DriscollChief Financial Officer | 2,500 | $9.19 | $22,972 | 5,934 | +72.8% | plan? |
| May 16, 2016 PForm 4 → | May 17, 6:10 pm EDT | Michael D. ClaymanPresident and CEO, Director | 2,000 | $9.51 | $19,025 | 5,568 | +56.1% | plan? |
| May 16, 2016 PForm 4 → | May 17, 6:08 pm EDT | Neil BodickChief Medical Officer | 1,250 | $9.22 | $11,525 | 72,187 | +1.76% | plan? |
| Sep 11, 2015 PForm 4 → | Sep 14, 4:32 pm EDT | C Ann MerrifieldDirector | 1,000 | $23.00 | $23,000 | 1,000 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 22, 6:22 pm EDT | A/S Novo10% Owner | 150,000 | $20.61 | $3,091,973 | 2,133,131 | −6.57% | plan? |
| May 20, 2015 JForm 4 → | May 27, 3:10 pm EDT | Frederick W DriscollChief Financial Officer | 1,311 | $11.91 | $15,614 | 2,754 | — | plan? late |
| May 20, 2015 JForm 4 → | May 27, 3:07 pm EDT | Michael D. ClaymanPresident and CEO, Director | 1,784 | $11.91 | $21,247 | 282,229 | — | plan? late |
| Mar 24, 2015 MForm 4 → | Mar 25, 4:01 pm EDT | Michael D. ClaymanPresident and CEO, Director | 5,000 | $0.1626 | $813 | 280,445 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 16, 5:19 pm EDT | Neil BodickChief Medical Officer | 4,000 | $25.28 | $101,115 | 70,937 | −5.34% | plan? |
| Mar 10, 2015 SForm 4 → | Mar 11, 2:22 pm EDT | Neil BodickChief Medical Officer | 4,000 | $24.26 | $97,055 | 74,937 | −5.07% | plan? |
| Mar 4, 2015 SForm 4 → | Mar 5, 8:50 pm EST | Neil BodickChief Medical Officer | 4,000 | $23.45 | $93,790 | 78,937 | −4.82% | plan? |
| Feb 26, 2015 SForm 4 → | Feb 26, 8:25 pm EST | Neil BodickChief Medical Officer | 4,000 | $22.44 | $89,766 | 82,937 | −4.60% | plan? |
| Oct 29, 2014 SForm 4 → | Jan 22, 2015, 2:02 pm EST | Sofinnova Partners SAS10% Owner | 10,000 | $20.00 | $200,000 | 2,095,491 | −0.47% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 AForm 4 → | Mar 5, 6:18 pm EST | Kerry WentworthChief Regulatory Officer | 18,000 | — | — | 18,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 5:32 pm EST | Scott KelleyChief Medical Officer | 18,000 | — | — | 18,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:30 pm EST | Christina WillwerthChief Strategy Officer | 18,000 | — | — | 18,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:29 pm EST | Mark S. LevineGeneral Counsel | 18,000 | — | — | 18,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:27 pm EST | David ArkowitzChief Financial Officer | 18,000 | — | — | 18,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:26 pm EST | Neil BodickChief Scientific Officer | 18,000 | — | — | 18,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 4:23 pm EST | Michael D. ClaymanPresident and CEO, Director | 360,000 | — | — | 360,000 | — | |
| Oct 8, 2018 MForm 4 → | Oct 9, 5:08 pm EDT | Neil BodickChief Scientific Officer | 4,566 | — | — | 4,568 | — | |
| Oct 8, 2018 MForm 4 → | Oct 9, 4:31 pm EDT | Michael D. ClaymanPresident and CEO, Director | 14,800 | — | — | 14,800 | — | |
| Oct 6, 2018 MForm 4/A → | Mar 5, 2019, 8:17 pm EST | Kerry WentworthChief Regulatory Officer | 3,400 | — | — | 3,400 | — | |
| Jun 20, 2018 AForm 4 → | Jun 21, 4:23 pm EDT | Mark StejbachDirector | 12,500 | — | — | 12,500 | — | |
| Jun 20, 2018 AForm 4 → | Jun 21, 4:21 pm EDT | Alan MilinazzoDirector | 12,500 | — | — | 12,500 | — | |
| Jun 20, 2018 AForm 4 → | Jun 21, 4:20 pm EDT | C Ann MerrifieldDirector | 12,500 | — | — | 12,500 | — | |
| Jun 20, 2018 AForm 4 → | Jun 21, 4:16 pm EDT | Sandesh MahatmeDirector | 12,500 | — | — | 12,500 | — | |
| Jun 20, 2018 AForm 4 → | Jun 21, 4:14 pm EDT | Samuel D ColellaDirector, 10% Owner | 12,500 | — | — | 12,500 | — | |
| Jun 20, 2018 AForm 4 → | Jun 21, 4:10 pm EDT | Scott A CanuteDirector | 12,500 | — | — | 12,500 | — | |
| Jun 20, 2018 AForm 4 → | Jun 21, 4:08 pm EDT | Patrick J MahaffyDirector | 18,000 | — | — | 18,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 4:26 pm EDT | David ArkowitzChief Financial Officer | 115,000 | — | — | 115,000 | — | |
| May 11, 2018 MForm 4 → | May 11, 4:07 pm EDT | Neil BodickChief Scientific Officer | 37,702 | — | — | 0 | — | |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:48 pm EST | Kerry WentworthChief Regulatory Officer | 33,333 | — | — | 33,333 | — | |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:47 pm EST | Scott KelleyChief Medical Officer | 33,333 | — | — | 33,333 | — | |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:45 pm EST | Mark S. LevineGeneral Counsel | 33,333 | — | — | 33,333 | — | |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:41 pm EST | Michael D. ClaymanPresident and CEO, Director | 116,667 | — | — | 116,667 | — | |
| Feb 1, 2018 AForm 4 → | Feb 2, 4:39 pm EST | Neil BodickChief Scientific Officer | 40,000 | — | — | 40,000 | — | |
| Oct 6, 2017 MForm 4 → | Oct 10, 4:43 pm EDT | Neil BodickChief Scientific Officer | 4,566 | — | — | 9,134 | — | |
| Oct 6, 2017 MForm 4 → | Oct 10, 4:39 pm EDT | Michael D. ClaymanPresident and CEO, Director | 14,800 | — | — | 29,600 | — | |
| Aug 28, 2017 PForm 4 → | Sep 15, 5:12 pm EDT | Yamo DenizChief Medical Officer | 30 | $3.77 | $113 | 10 | — | late |
| Jun 26, 2017 AForm 4 → | Jun 26, 9:20 pm EDT | Mark S. LevineSVP & General Counsel | 125,000 | — | — | 125,000 | — | |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:44 am EDT | Mark StejbachDirector | 12,500 | — | — | 12,500 | — | late |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:43 am EDT | Alan MilinazzoDirector | 12,500 | — | — | 12,500 | — | late |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:41 am EDT | C Ann MerrifieldDirector | 12,500 | — | — | 12,500 | — | late |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:40 am EDT | Sandesh MahatmeDirector | 12,500 | — | — | 12,500 | — | late |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:38 am EDT | Heath LukatchDirector | 12,500 | — | — | 12,500 | — | late |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:37 am EDT | Samuel D ColellaDirector, 10% Owner | 12,500 | — | — | 12,500 | — | late |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:36 am EDT | Scott A CanuteDirector | 12,500 | — | — | 12,500 | — | late |
| Jun 22, 2017 AForm 4 → | Jul 27, 9:34 am EDT | Patrick J MahaffyDirector | 18,000 | — | — | 18,000 | — | late |
| May 15, 2017 MForm 4/A → | May 19, 4:34 pm EDT | Neil BodickChief Medical Officer | 6,830 | — | — | 37,472 | — | |
| Apr 17, 2017 MForm 4/A → | May 19, 4:32 pm EDT | Neil BodickChief Medical Officer | 5,000 | — | — | 44,302 | — | |
| Apr 3, 2017 AForm 4 → | Apr 5, 5:18 pm EDT | Yamo DenizChief Medical Officer | 150,000 | — | — | 150,000 | — | |
| Mar 23, 2017 MForm 4 → | Mar 24, 4:24 pm EDT | Frederick W DriscollChief Financial Officer | 3,000 | — | — | 102,300 | — | |
| Mar 17, 2017 MForm 4/A → | May 19, 4:31 pm EDT | Neil BodickChief Medical Officer | 5,000 | — | — | 49,302 | — | |
| Feb 28, 2017 MForm 4 → | Mar 2, 4:56 pm EST | Frederick W DriscollChief Financial Officer | 30,000 | — | — | 105,300 | — | |
| Feb 24, 2017 MForm 4/A → | May 19, 4:28 pm EDT | Neil BodickChief Medical Officer | 4,000 | — | — | 54,302 | — | |
| Dec 20, 2016 AForm 4 → | Dec 22, 4:38 pm EST | Frederick W DriscollChief Financial Officer | 50,000 | — | — | 50,000 | — | |
| Dec 20, 2016 AForm 4 → | Dec 22, 4:34 pm EST | Michael D. ClaymanPresident and CEO, Director | 175,000 | — | — | 175,000 | — | |
| Dec 20, 2016 AForm 4 → | Dec 22, 4:32 pm EST | Neil BodickChief Medical Officer | 65,000 | — | — | 65,000 | — | |
| Sep 13, 2016 AForm 4 → | Sep 14, 4:20 pm EDT | Mark StejbachDirector | 25,000 | — | — | 25,000 | — | |
| Jun 10, 2016 AForm 4/A → | Jun 22, 6:17 pm EDT | Patrick J MahaffyDirector | 18,000 | — | — | 18,000 | — | |
| Jun 10, 2016 AForm 4/A → | Jun 22, 6:15 pm EDT | Heath LukatchDirector | 12,500 | — | — | 12,500 | — | |
| Jun 10, 2016 AForm 4/A → | Jun 22, 6:14 pm EDT | Alan MilinazzoDirector | 12,500 | — | — | 12,500 | — | |
| Jun 10, 2016 AForm 4/A → | Jun 22, 6:11 pm EDT | Samuel D ColellaDirector, 10% Owner | 12,500 | — | — | 12,500 | — | |
| Jun 10, 2016 AForm 4/A → | Jun 22, 5:59 pm EDT | Sandesh MahatmeDirector | 12,500 | — | — | 12,500 | — | |
| Jun 10, 2016 AForm 4/A → | Jun 22, 5:54 pm EDT | Scott A CanuteDirector | 12,500 | — | — | 12,500 | — | |
| Jun 10, 2016 AForm 4 → | Jun 13, 8:34 pm EDT | Alan MilinazzoDirector | 12,500 | — | — | 12,500 | — | amended |
| Jun 10, 2016 AForm 4 → | Jun 13, 8:33 pm EDT | C Ann MerrifieldDirector | 12,500 | — | — | 12,500 | — | |
| Jun 10, 2016 AForm 4 → | Jun 13, 8:31 pm EDT | Sandesh MahatmeDirector | 12,500 | — | — | 12,500 | — | amended |
| Jun 10, 2016 AForm 4 → | Jun 13, 8:29 pm EDT | Patrick J MahaffyDirector | 18,000 | — | — | 18,000 | — | amended |
| Jun 10, 2016 AForm 4 → | Jun 13, 8:27 pm EDT | Heath LukatchDirector | 12,500 | — | — | 12,500 | — | amended |
| Jun 10, 2016 AForm 4 → | Jun 13, 8:25 pm EDT | Samuel D ColellaDirector, 10% Owner | 12,500 | — | — | 12,500 | — | amended |
| Jun 10, 2016 AForm 4 → | Jun 13, 8:22 pm EDT | Scott A CanuteDirector | 12,500 | — | — | 12,500 | — | amended |
| May 23, 2016 MForm 4 → | May 24, 5:26 pm EDT | Michael D. ClaymanPresident and CEO, Director | 10,369 | — | — | 0 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:30 pm EST | Frederick W DriscollChief Financial Officer | 65,650 | — | — | 25,650 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:29 pm EST | Michael D. ClaymanPresident and CEO, Director | 221,600 | — | — | 66,600 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:28 pm EST | Neil BodickChief Medical Officer | 75,550 | — | — | 20,550 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:20 pm EDT | Alan MilinazzoDirector | 9,000 | — | — | 9,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:19 pm EDT | C Ann MerrifieldDirector | 9,000 | — | — | 9,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:18 pm EDT | Sandesh MahatmeDirector | 9,000 | — | — | 9,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:16 pm EDT | Heath LukatchDirector | 9,000 | — | — | 9,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:15 pm EDT | Samuel D ColellaDirector, 10% Owner | 9,000 | — | — | 9,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:14 pm EDT | Scott A CanuteDirector | 9,000 | — | — | 9,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:12 pm EDT | Patrick J MahaffyDirector | 18,000 | — | — | 18,000 | — | |
| Mar 24, 2015 MForm 4 → | Mar 25, 4:01 pm EDT | Michael D. ClaymanPresident and CEO, Director | 5,000 | — | — | 10,369 | — | |
| Mar 4, 2015 AForm 4 → | Mar 6, 4:36 pm EST | Scott A CanuteDirector | 18,000 | — | — | 18,000 | — | |
| Jan 21, 2015 AForm 4 → | Jan 23, 1:47 pm EST | Frederick W DriscollChief Financial Officer | 40,000 | — | — | 40,000 | — | |
| Jan 21, 2015 AForm 4 → | Jan 23, 1:45 pm EST | Michael D. ClaymanPresident and CEO, Director | 110,000 | — | — | 110,000 | — | |
| Jan 21, 2015 AForm 4 → | Jan 23, 1:45 pm EST | Neil BodickChief Medical Officer | 45,000 | — | — | 45,000 | — |